We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+57.96%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$1.28B
AUM Growth
+$424M
Cap. Flow
+$743K
Cap. Flow %
0.06%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$2.71M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$1.97M

Sector Composition

Rank Sector Weight
1 Healthcare 56.68%
2 Consumer Staples 25.23%
3 Miscellaneous 12.26%
4 Industrials 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.13B
$665M 51.95%
10,799,410
– –
MNST icon
2
Monster Beverage
MNST
$87.7B
$323M 25.23%
18,625,952
– –
IWM icon
3
iShares Russell 2000 ETF
IWM
$77.2B
$157M 12.26%
1,095,000
-15,000
-1% -$1.97M
AXON
4
Axon Enterprise
AXON
$38.4B
$74.6M 5.83%
760,062
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$29.6M 2.31%
34,005,379
– –
IMDX
6
Insight Molecular Diagnostics
IMDX
$125M
$28.1M 2.2%
735,810
+52,500
+8% +$2.71M
SER icon
7
Serina Therapeutics
SER
$58.2M
$2.84M 0.22%
85,219
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Broadwood Capital held 7 positions worth $1.28B, up 50% from $856M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2020: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Miscellaneous.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q2 2020, an estimated $2.71M increase.
  • Broadwood Capital's biggest Q2 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $1.97M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.28B portfolio in Q2 2020.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2020.
  • Broadwood Capital's portfolio value rose 50% quarter-over-quarter to $1.28B.

Based on Broadwood Capital's 13F filing for Q2 2020, filed 14 Aug 2020.